These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12092683)

  • 21. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone secretory pattern and response to treatment in children with short stature followed to adult height.
    Radetti G; Buzi F; Cassar W; Paganini C; Stacul E; Maghnie M
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):27-33. PubMed ID: 12807500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Height gain at adult-height age in 184 short patients treated with growth hormone from prepubertal age to near adult-height age is not related to GH secretory status at GH therapy onset.
    Carrascosa A; Audí L; Fernández-Cancio M; Yeste D; Gussinye M; Campos A; Albisu MA; Clemente M; Bel J; Nosás R; Rabanal M; Del Pozo C; Gómez JM; Mesa J;
    Horm Res Paediatr; 2013; 79():145-56. PubMed ID: 23548791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth without growth hormone: growth pattern and final height of five patients with idiopathic combined pituitary hormone deficiency.
    Lazar L; Dan S; Phillip M
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):82-8. PubMed ID: 12807508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Septo-optic dysplasia in childhood: the neurological, cognitive and neuro-ophthalmological perspective.
    Signorini SG; Decio A; Fedeli C; Luparia A; Antonini M; Bertone C; Misefari W; Ruberto G; Bianchi PE; Balottin U
    Dev Med Child Neurol; 2012 Nov; 54(11):1018-24. PubMed ID: 22924461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onset of pituitary hormone deficiencies in optic nerve hypoplasia: a temporal trend analysis of 32 children at Mayo Clinic.
    Wadams HD; Gupta N; Novotny P; Tebben PJ
    J Pediatr Endocrinol Metab; 2020 Jan; 33(1):139-145. PubMed ID: 31811804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO; Lindberg A; Ranke MB; Price DA; Albertsson-Wikland K; Cowell CT; Bakker B
    Horm Res; 2003; 60(Suppl 1):68-73. PubMed ID: 12955021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone deficiency of hypothalamic origin in septo-optic dysplasia.
    Yukizane S; Kimura Y; Yamashita Y; Matsuishi T; Horikawa H; Ando H; Yamashita F
    Eur J Pediatr; 1990 Nov; 150(1):30-3. PubMed ID: 2079074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of the growth response of short prepubertal children treated with growth hormone. Swedish Paediatric Study Group for GH treatment.
    Kriström B; Karlberg J; Albertsson-Wikland K
    Acta Paediatr; 1995 Jan; 84(1):51-7. PubMed ID: 7734899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone therapy in children after cranial/craniospinal radiation therapy: sexually dimorphic outcomes.
    Lerner SE; Huang GJ; McMahon D; Sklar CA; Oberfield SE
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6100-4. PubMed ID: 15579765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Septo-optic dysplasia.
    Ferran Kd; Paiva IA; Gilban DL; Resende M; Souza MA; Beserra IC; Guimarães MM
    Arq Neuropsiquiatr; 2010 Jun; 68(3):400-5. PubMed ID: 20602044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Earlier initiation of GH therapy does not influence adult height but enables earlier start of pubertal induction in children with multiple pituitary hormone deficiency.
    Kawai M; Momoi T; Mamada M; Yorifuji T; Nakahata T
    Clin Endocrinol (Oxf); 2004 May; 60(5):608-12. PubMed ID: 15104564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T; Mulder P; Hokken-Koelega A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of the National Cooperative Growth Study substudy of serial growth hormone measurements.
    Blethen SL; Breen TJ; Attie KM
    J Pediatr; 1996 May; 128(5 Pt 2):S38-41. PubMed ID: 8627467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Final height after growth hormone therapy in short children: correlation with siblings' height.
    Zadik Z; Zung A
    Horm Res; 1997; 48(6):274-7. PubMed ID: 9402245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple pituitary hormone deficiency: management of puberty for optimal auxological results.
    Stanhope R; De Luca F; Delemarre-Van de Waal HA; Liotta A; Norjavaara E; Salvatoni A; Wu F;
    J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 2():1009-14. PubMed ID: 11529397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone deficiency and related disorders: insights into causation, diagnosis, and treatment.
    Dattani M; Preece M
    Lancet; 2004 Jun; 363(9425):1977-87. PubMed ID: 15194259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with GH and cyproterone acetate does not improve final height in boys with non-GH-deficient short stature.
    Kawai M; Momoi T; Yorifuji T; Muroi J; Yamanaka C; Sasaki H; Furusho K
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):53-7. PubMed ID: 9509068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.